Communiqués Cogstate Limited

Actions

CGS

AU000000CGS8

Marché Fermé - Australian S.E. Autres places de cotation 08:10:50 02/07/2024			Varia. 5j.	Varia. 1 janv.
1,1 ^AUD	-0,90%		-1,35%	-23,88%

01/04	Cogstate modifie son accord de licence avec Eisai pour le traitement de la maladie d'Alzheimer	MT
22/02	Le bénéfice attribuable de Cogstate pour le premier semestre fiscal bondit, le chiffre d'affaires augmente de 3% ; les actions baissent de 8%.	MT

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

IntelGenx Completes Enrollment for 'BUENA' Montelukast VersaFilm Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer's Disease	02/08/23	AQ
Cogstate : Business Update and June 2022 Quarter Cashflow	28/07/22	PU
Cogstate : Joins New Collaborative of Global Healthcare Leaders to Define Core Digital Measures for Alzheimer’s Disease	20/06/22	PU
Cogstate Announces Formation of Scientific Advisory Board	14/06/22	GL
Cogstate : Announces Formation of Scientific Advisory Board	14/06/22	PU
Cogstate : Investor Update	21/04/22	PU
Cogstate : Business Update and March 2022 Quarter Cashflow	21/04/22	PU
Cogstate : Half Year Report – H1 FY2022	23/02/22	PU
Cogstate : 1H22 Financial Results & Business Update	23/02/22	PU
Cogstate : Investor Briefing	23/02/22	PU
Cogstate : App 4D and Financial Statements Half-year Ended 31 Dec 2021	23/02/22	PU
Cogstate : Appendix 4D and Financial Statements for Half-year Ended 31 December 2021	23/02/22	PU
Cogstate : Investor Update	20/01/22	PU
Cogstate : Business Update and December 2021 Quarter Cashflow	20/01/22	PU
EISAI TO LAUNCH DIGITAL TOOL 'CogMate' IN TAIWAN AND HONG KONG FOR SELF-ASSESSMENT OF BRAIN PERFORMANCE (BRAIN HEALTH)	13/01/22	AQ
Cogstate : Eisai to Launch Digital Tool “Cogmate™ in Taiwan And Hong Kong	13/01/22	PU
Cogstate : Notification regarding unquoted securities - CGS	03/12/21	PU
Cogstate : Technology to be Installed on Japanese Smartphone Targeting Senior Population	30/11/21	PU
Cogstate : Clinical Trial in Dementia with Lewy Bodies Used Cogstate Digital Assessments and Data Quality Services to Support the Evaluation of Neflamapimod	29/11/21	PU
Innovation Investor Conference Presentations Now Available for On-Demand Viewing	07/12/20	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Cogstate Limited

Actions

CGS

AU000000CGS8

Communiqués

Filtres